Capitalnumbers Infotech shareholders have approved the reallocation of ₹11.46 crore in unutilized IPO funds toward the ₹40 crore acquisition of Epitome Cloud Inc. The move signals a strategic inorganic growth push, with the acquisition of the cloud entity and its Indian subsidiary slated for completion by September 2028.
Capitalnumbers Infotech Reallocates IPO Funds for Strategic Acquisition
- Reallocation of ₹11.46 crore of unutilized IPO funds approved by shareholders.
- Total acquisition cost for Epitome Cloud Inc. and its subsidiary is ₹40 crore.
Reader Takeaway: Strategic pivot to inorganic growth via acquisition, utilizing existing unspent IPO proceeds without additional capital raising.
What just happened
Capitalnumbers Infotech Ltd received shareholder approval at its September 29, 2026, Annual General Meeting to change the utilization of its IPO proceeds. The company is reallocating ₹1,146.46 lakh, previously earmarked for 'Issue Related Expenses,' to finance the 100% acquisition of Epitome Cloud Inc. and its Indian subsidiary, Epitomecloud Technology Private Limited. The company has clarified that this reallocation does not impact the total net proceeds raised during its initial public offering.
Why this matters
The acquisition is a key component of the company's inorganic growth strategy. By shifting unspent issue expenses, Capitalnumbers Infotech is effectively deploying capital toward business expansion without needing to raise fresh equity. The deal is expected to be finalized by September 2028, pending customary regulatory and closing conditions.
Scope Expansion
Beyond the fund reallocation, the company has broadened the scope of its 'Investment in Subsidiary' object. Originally restricted to Capital Numbers LLC, the mandate now covers the newly acquired Epitome Cloud Inc. and its associated entities. The total budget for this specific objective remains fixed at ₹500 lakh.
Risks to watch
As with any acquisition, the integration of Epitomecloud and its subsidiary into the parent company’s operations carries execution risks. Investors should monitor the progress of the acquisition timeline, which extends to September 2028, and potential shifts in the operational efficiency of the target firms post-acquisition.
What to track next
Shareholders should look for management updates regarding the definitive closing of the transaction and how the integration of Epitome Cloud’s technological capabilities impacts the company's consolidated revenue streams.